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ABSTRACT  
Polymeric nanoparticles (NPs) are attractive candidates for the controlled and targeted delivery 
of therapeutics in vitro and in vivo. However, detailed understanding of the uptake, location and 
ultimate cellular fate of the NPs is necessary in order to satisfy safety concerns, which is difficult 
because of the nanoscale size of these carriers. In this work, we show how small chemical labels 
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can be appended to poly(lactic acid-co-glycolic acid) (PLGA) in order to synthesise NPs that can 
then be imaged by stimulated Raman scattering (SRS) microscopy, a vibrational imaging 
technique which can elucidate bond specific information in biological environments, such as the 
identification of alkyne signatures in modified PLGA terpolymers. We show that both deuterium 
and alkyne labelled NPs can be imaged within primary rat microglia, and the alkyne NPs can 
also be imaged ex vivo cortical mouse brain tissue. Immunohistochemical analysis confirms that 
the NPs localize in microglia in the mouse brain tissue, demonstrating that these NPs have the 
potential to deliver therapeutics selectively to microglia.  
KEYWORDS  
Nanoparticles, drug delivery, alkynes, Raman imaging, bioorthogonal polymers, stimulated 
Raman scattering 
 
INTRODUCTION  
The use of polymeric NPs for drug delivery has become increasingly popular in order to achieve 
controlled release, targeted delivery and increased lifetime of therapeutics in vivo. NP drug 
delivery can have wide ranging applications such as the targeting of cancer therapeutics,1,2 
delivery of drugs to the brain,3,4 and encapsulation protein therapeutics, which are sensitive to 
certain biological environments and may degrade to an inactive form in vivo. PLGA micro and 
nanoparticles have been used extensively in drug delivery research as they are FDA approved, 
biocompatible and biodegradable.5 However, due to the nanoscale size of these drug carriers, 
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imaging their uptake, bio-distribution and ultimate cellular fate in vitro and in vivo is 
challenging.  
Previous efforts to image polymer NPs have mainly focused on the encapsulation of fluorescent 
dyes inside the NPs to allow imaging by fluorescence microscopy,6 or by various Raman-based 
methods, which we have recently reviewed.7 The degradation of PLGA NPs in macrophages has 
been monitored by quantifying the loss of fluorescent signal over time.8 PLGA NPs degrade by 
hydrolysis under physiological conditions,9 thus the loss of fluorescent signal could correspond 
to dye being released from the NPs, and not give direct information about the location and state 
of the NP. Also, fluorophores are generally unstable in biological environments, and 
photobleaching can also cause signal degradation of the dye (Figure 1).10  
Stimulated Raman scattering (SRS) microscopy has emerged as a powerful, label-free optical 
imaging technique for biological systems that can provide quantitative and bond-specific cellular 
information.11,12 Spontaneous Raman scattering can be used to probe the chemical signature of 
cells and biological tissues due to the inelastic scattering of light when the sample is irradiated 
with a laser, but recording an image may take many minutes to hours. With coherent Raman 
techniques like SRS, a specific vibrational bond can be probed using two lasers tuned to the 
bond’s energy difference. This drives a coherent resonance allowing video rate imaging to be 
achieved.13 
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Figure 1. Illustrative summary of different strategies for intracellular NP imaging. Fluorescent 
dyes have been encapsulated in NPs to allow visualisation. Disadvantages of this approach are 
that dye can leach out of the NPs and suffer from photobleaching. In this work we directly label 
the polymer with a bioorthogonal Raman tag. Image created with Biorender.com.  
In contrast to infrared, Raman spectroscopy has a low background interference from water 
making it ideally suited to study biological samples. Due to the absence of any cellular 
vibrational peaks in the spectroscopic region between 1800 and 2800 cm-1, known as the cell-
silent region, small, bioorthogonal chemical tags (for example C-D, C≡C and C≡N) which 
resonate in this region can be exploited to give imaging free of cellular background.14–19 As such, 
poly(phenylene ethynylene) NPs, which have an intrinsic alkyne, have been visualised in HeLa 
cells with spontaneous Raman imaging.20 More recently, SRS has been used to image NP 
polymer dots bearing alkyne (2163 cm-1), nitrile (2232 cm-1) and carbon-deuterium (2293 cm-1) 
bonds, which all produce peaks in the cell silent region.21 
In this work, we have explored two analogues of PLGA, with deuterium and alkyne labels which 
are Raman active in the cell-silent region. These polymers were then formulated into NPs and 
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imaged firstly in cultured primary microglia and then in ex vivo brain tissue by SRS microscopy. 
As opposed to imaging a fluorescent payload, our approach allows direct imaging of the 
nanoparticle itself, and can be used to monitor the cellular location of the NPs. SRS microscopy 
gives a signal enhancement over spontaneous Raman imaging, and also a 1000 fold improvement 
in image acquisition speed.22 We have therefore used SRS to image NP analogues of PLGA, a 
highly relevant biocompatible and biodegradable polymer.  
MATERIALS AND METHODS 
Synthesis of PLGA: Under a nitrogen atmosphere D,L-lactide (8.0 g, 55 mmol) and glycolide 
(2.8 g, 24 mmol) were added to a preheated round bottom flask containing stannous octanoate 
(0.16 g, 0.40 mmol) and dodecanol (0.07 g, 0.40 mmol) at 130°C. The reaction mixture was 
heated and stirred for a further hour until complete conversion was reached. After the reaction 
was cooled to room temperature, it was dissolved in dichloromethane (DCM) (5 mL) and 
precipitated in cold methanol (400 mL). The solvent was decanted off, leaving a colorless solid 
which was dried in vacuo until constant weight. 1H NMR (500 MHz, Chloroform-d) δ 5.30 – 
5.11 (9H, m, CH), 4.97 – 4.58 (7H, m, CH2), 1.64 – 1.49 (23H, m, CH3); GPC Mn = 5700 g/mol, 
Ð = 1.11.  
Synthesis of PLGA-D: D,L-Lactic acid (0.10 g, 0.94 mmol; 85% in water), L-lactic acid-d3 (0.10 
g, 0.91 mmol; 85% in water) and glycolic acid (0.06 g, 0.79 mmol) were dehydrated at 150°C for 
8 h in a flask fitted with an air condenser containing molecular sieves to form oligomers. Tin 
chloride (0.5 wt%) and para-toluene sulfonic acid (0.5 wt%) were then added to the oligomers 
followed by heating to 180°C for a further 8 h. The crude polymer was dissolved in DCM (2 mL) 
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and precipitated into a 50:50 mixture of ice-cold hexane/ether (100 mL) to yield a colorless solid 
which was dried in vacuo until constant weight. 1H NMR (400 MHz, Chloroform-d) δ 5.30-5.13 
(1H, m, CH), 4.93-4.56 (2H, m, CH2), 1.64-1.51 (3H, m, CH3). GPC Mn = 4553 g/mol, Ð = 1.84. 
Synthesis of PLGA-alkyne: In a glovebox, PLGA (2.00 g, 0.56 mmol), propargyl-DOX (0.38 g, 
2.78 mmol, see Scheme S2), and SnOct2 (0.23 g, 0.56 mmol) were dissolved in toluene (4 mL) 
and charged to a Schlenk flask. The flask was removed from the glovebox and heated at 110°C 
for 24 h. After the reaction was cooled to room temperature, the reaction mixture was diluted 
further by the addition of DCM (5 mL) and the mixture was precipitated in cold methanol (400 
mL). The solvent was decanted off leaving a colourless solid which was dried in vacuo until 
constant weight. 1H NMR (500 MHz, Chloroform-d) δ 5.43 – 5.11 (m, 9H), 4.97 – 4.58 (m, 7H), 
2.99 – 2.77 (m, 2H), 2.14 – 2.03 (br s, 1H), 1.64 – 1.49 (m, 23H). GPC Mn = 5900 g/mol, Ð = 
1.88. 
Nanoparticle synthesis and characterisation: A solution of PLGA-D/PLGA-alkyne (10-20 
mg) in DCM (1 mL) was added to an aqueous solution of 1% polyvinyl alcohol (MW 31 000 – 
50 000 Da, 98-99% hydrolysed) and 0.2% sodium dodecyl sulphate (10 mL). The two phases 
were emulsified using a probe tip sonicator (Soniprep 150, MSE) for 2 minutes. The resulting 
emulsion was stirred at room temperature overnight to allow evaporation of the DCM. The 
nanoparticles were collected by centrifugation at 8000 rpm for 10 minutes, and washed once 
with deionised water. Nanoparticle tracking analysis measurements were carried out in triplicate 
in 1 × PBS on a NanoSight LM10 (Malvern Panalytical) for 60 seconds with the temperature 
measured for each individual run. The samples were diluted until in the range of 1-8 × 108 
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particles mL-1 for more accurate measurements. Dynamic light scattering (DLS) was carried out 
on a Zetasizer Nano ZS (Malvern Panalytical) in water at 25°C. 
Spontaneous Raman: Spontaneous Raman spectra were acquired on a confocal Raman 
spectrometer (inVia Raman microscope, Renishaw). A 297 mW (206 mW after objective) 785 
nm diode laser, or a 200 mW 532 nm laser excitation source was used to excite the sample 
through a 20× or 50× objective. All spectra were background subtracted using the background 
correction algorithm available on the Wire 4.4 software.  
SRS setup: Images were acquired using a custom-built multi-modal microscope. A picoEmerald 
(APE, Berlin, Germany) laser gave a tuneable pump laser (720-990 nm, 7 ps, 80 MHz repetition 
rate) and a spatially and temporally overlapped Stokes laser (1064 nm, 5-6 ps, 80 MHz repetition 
rate). Back scattered RFP two-photon fluorescence signals were filtered using the following 
series of filters: FF552-Di02, FF440/520-Di01 (Semrock) and HQ610/75m (Chroma). For SRS 
measurements, the Stokes beam was modulated with a 20 MHz EoM. Forward scattered light 
was collected by a 20× Olympus XLUMPLFLN Objective, 1.00 NA lens and filtered 
using ET890/220m filter (Chroma). A telescope focused the light onto an APE silicon 
photodiode connected to an APE lock-in amplifier which was fed into the analogue unit of the 
microscope. 
The pump laser was tuned to 810.5 nm (2930 cm-1, protein), 816 nm (2850 cm-1, lipid), 867.5 nm 
(2128 cm-1, C≡C) and 858.3 nm (2252 cm-1, C-D), and laser powers after the objective were 
measured up to 40-70 mW for the pump laser, and up to 70 mw for the Stokes laser. All images 
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were recorded at 512 × 512 or 1024 × 1024 pixels with a pixel dwell time between 2 and 20 μs 
by FV10-ASW software (Olympus).  
General procedures for cell culture: Microglia cultures were prepared from neonatal Sprague-
Dawley rats. Mixed glia cultures were isolated from postnatal day 1-2 rat pups, and after 10 days 
microglia were isolated by shaking the culture flasks and relying on differential adhesion of 
oligodendrocyte precursor cells, microglia and astrocytes.23 Microglia were cultured in 
Dulbecco’s Modified Eagle Media (Gibco) + 10% fetal bovine serum + 1% penicillin 
streptomycin, and were incubated at 37°C in a humidified atmosphere with 7.5% CO2 and media 
changes every 2-3 days. To improve cell adherence, all culture dishes were coated in poly-D-
lysine before plating the cells by covering dishes in a 1 µg/mL aqueous solution and incubating 
at 37°C for one hour, before removing the solution and washing once with sterile water. Cell 
fixation was achieved by covering the cells with a solution of 4% formaldehyde (2 mL) for 10 
minutes at room temperature before washing three times with 1 × PBS (3 × 2 mL). 
SRS microglia experiments: Microglia were plated at 3 × 105 cells per well in FluoroDish Cell 
Culture Dishes (World Precision Instruments) and left overnight to adhere to the dish. NPs 
(alkyne or deuterium) were then added at 2 × 109 particles mL-1 followed by a 24 hour 
incubation. The media was then removed and the cells were washed twice with 1 × PBS (2 × 2 
mL) before fixation and imaging with the SRS set-up described above.  
Slice culture experiments: Brains were isolated from P5 C57BL6/N mice pups in cold 
Hibernate-A medium (Thermo Fisher A12475-01) on ice and cut into 300 µm cortical slices 
using a vibratome (Leica). The slices were then transferred to Millipore milli cell-CM 
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organotypic inserts (30 mm, hydrophilic PTFE, 0.4 µm, Merck-Millipore, PICM0RG50) in slice 
media (50% MEM (Invitrogen, 32360-026) with 25% Earle’s Balanced Salt Solution 
(Invitrogen, 24010-043), 25% heat-inactivated horse serum (Invitrogen, 26050-088), 1% 
glutamax supplement (Invitrogen, 35050-038), 1% penicillin–streptomycin, 0.5% Fungizone 
(Invitrogen, 15290-018) and 6.5 mg/ml glucose (Sigma G8769)), and were maintained at 37 °C 
and 7.5% CO2 with media changes every two days. After 6 days in culture, alkyne NPs were 
added at 2 × 108 and 2 × 109 particles mL-1 for 24 hours. The slices were then washed twice with 
1 × PBS (2 × 2 mL) before fixation. Slices were fixed with 4% formaldehyde (2 mL) for one 
hour at room temperature before washing three times with 1 × PBS (3 × 2 mL). 
Immunostaining of slices: Fixed slices in a 6 well plate were incubated with blocking solution 
(3% HIHS, 2% BSA, 0.5% Triton in PBS) (1 mL per well) for 2 h before adding the primary 
antibodies. Rabbit polyclonal anti-IBA1 (1/500, Abcam, AB178846) and mouse monoclonal 
anti-OLIG2 (1/500, Merck Millipore, MABN50) were diluted in blocking solution and 500 µL 
was added to each well. The slices were then shaken at 4 °C for 1.5 days before washing three 
times for 1 h with blocking solution (3 × 2 mL). The secondary antibodies, goat anti-rabbit 568 
(1/1000, Life Technologies, A11011) and donkey anti-mouse 488 (1/1000, Thermo Fisher 
Scientific, A21202) were diluted in blocking solution and then incubated with the slices (500 µL 
per well) with gentle agitation overnight, in the dark at 4 °C. The slices were then washed once 
for 10 minutes followed by three 1 h washes with 1 × PBS (4 × 2 mL) and finally imaged using 
the SRS set-up described above.  
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Image processing: All images were processed with the Fiji image processing package 
(https://imagej.net/Fiji). False colour assignments and scale bars were added to images. Image 
overlays and orthogonal views were also processed with Fiji.  
RESULTS AND DISCUSSION 
Deuterated PLGA (PLGA-D) was synthesised via a direct poly-condensation method from lactic 
acid, lactic acid-d3 and glycolic acid, which produced a polymer with a molecular weight of 4.5 
kDa and a dispersity of 1.84 (Scheme 1A).24,25 Since Raman is an inherently weak effect, with 
only approximately 1 in every 108 molecules experiencing Raman scattering,26 a deuterium 
group was introduced into the monomer, as opposed to substitution onto a pre-made polymer, to 
maximise the Raman signal of the NPs.  
To produce the alkyne analogue of PLGA (PLGA-alkyne), PLGA was first synthesised by a ring 
opening copolymerisation of lactide and glycolide, using dodecanol as the initiator and stannous 
octanoate as the catalyst.27 Recent work has shown that 1,3-dioxolan-4-ones (DOX) are a 
versatile and sustainable family of monomers utilised for the synthesis of biodegradable 
polyesters by ring opening polymerisation. 28,29 To introduce the alkyne functionality, the 
telechelic properties of PLGA were exploited to initiate the polymerisation of propargyl-DOX 
(see Scheme S.2 for propargyl-DOX synthesis). Ring-opening polymerisation from the PLGA 
macroinitiator initially affords a blocky PLGA-P(propargyl-DOX) copolymer. However, 
extended reaction times lead to transesterification catalysed by stannous octanoate, scrambling 
the terpolymer structure to afford a statistical distribution of the alkyne units throughout the 
PLGA chain (Scheme 1B). This gave rise to a polymer with comparable molecular weight and 
dispersity to the deuterium analogue (5.9 kDa and 1.88 respectively). The incorporation of the 
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alkyne into the terpolymer was confirmed by a single cross peak in the diffusion-ordered 
spectroscopy (DOSY) NMR (Figure S2).  
 
Scheme 1. Synthesis of Raman active PLGA analogues. A) Synthesis of PLGA-D. Reagents 
and conditions: a; 150°C, 8 h, b; SnCl2, p-TSA, 180°C, 8 h. B) Synthesis of PLGA-alkyne. 
Reagents and conditions: c; Sn(oct)2, toluene, 110°C, 24 h.  
 
The Raman labelled polymers, along with unlabelled PLGA, were then characterised with 
spontaneous Raman spectroscopy (Figure 2). PLGA (black) was analysed as a control to show 
that there are no peaks in the cell-silent region. In contrast, the PLGA-D (red) shows multiple 
broad peaks between 2000 and 2300 cm-1, and the PLGA-alkyne (blue) shows a single, intense 
peak at 2128 cm-1. Notably, the alkyne signal presents a much stronger peak in the cell silent 
region than the deuterium, which is consistent with previous studies.17 
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Figure 2. Analysis of polymers by Spontaneous Raman spectroscopy. Spontaneous Raman 
spectra of PLGA (black), PLGA-D (red) and PLGA-alkyne (blue), with the labelled analogues 
showing peaks in the cell silent region. Spectra are normalised to the carbonyl peak (C=O) at 
1737 cm-1 and offset for clarity, λex=785 nm. 
 
The PLGA analogues were then fabricated into NPs using the standard, and widely used, 
emulsification-evaporation method (Figure 3A),30 which can be easily modified to encapsulate 
both hydrophobic and hydrophilic drugs. The NPs were analysed by nanoparticle tracking 
analysis (NTA), a technique which uses an optical microscope equipped with a laser to visualise 
particles according to the light they scatter.31,32 Individual particles were then tracked and their 
Brownian motion measured, which gives both particle size and particle concentration data 
(Figure 3B). This showed that the mean size of the PLGA-D and PLGA-alkyne particles are 87 
and 81 nm respectively. Visualisation of the particles by the NTA shows that they are uniform 
and well separated (Figure 3C). Due to the tendency of the PLGA-D NPs to aggregate over time 
(Figure S4), the NPs were freshly prepared before every biological experiment.  
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Figure 3. The synthesis and characterization of polymer NPs. A) A general representation of 
the emulsification-evaporation process. B) Particle size distribution acquired from the NTA of 
PLGA-alkyne (blue) and PLGA-D (red). Spectra are normalised between 0 and 1 and offset for 
clarity. C) A visual representation of the NPs detected by the NTA camera, which is proportional 
to the amount of light scattered by the particles.  
 
Next, we treated primary rat microglia with our two Raman active NPs. We chose microglia as 
‘proof of principle’ cells as they are phagocytes in the brain, and therefore likely to internalise 
the NPs.33 NPs can cross the blood-brain barrier, and so have great potential for delivery of cargo 
to the brain.34,35 The microglia used were primary cultures isolated from rat brains to retain more 
biologically relevant in vivo characteristics as opposed to using cell lines.  
14 
 
 
To test whether NPs were toxic to microglia, we used a luminescence cell viability assay 
which quantifies the amount of ATP, indicative of live cells. This assay found that PLGA, 
PLGA-D and PLGA-alkyne NPs were all non-toxic to microglia at all concentrations tested (1, 2 
and 4 × 109 particles mL-1) (Figure S5). 
 Microglia were then incubated with PLGA-D or PLGA-alkyne NPs for 24 hours before 
imaging with SRS microscopy (Figure 4). Tuning the energy difference between the pump and 
Stokes beams of the SRS microscope to 2939 cm-1 excites CH3 vibrations only, showing the 
protein content of the cells. Similarly, tuning to 2856 cm-1 excites CH2 vibrations, which is 
indicative of the cellular lipid content. Due to the bioorthogonal deuterium and alkyne chemical 
labels on our NPs, tuning to 2253 cm-1 (C-D) and 2128 cm-1 (C≡C) respectively allowed 
visualisation of the cellular location of the NPs, which were shown to be distributed throughout 
the cytoplasm and absent from the nuclei. Z-stack analysis of the cells also confirmed that the 
NPs had been internalised (Figure S6). 
Time dependent analysis of PLGA-alkyne NP internalisation into microglia was also carried 
out over 24 hours. The alkyne intensity of individual cells at 0, 12 and 24 hours were quantified, 
and this showed that the alkyne intensity, and therefore the intensity of NPs, increased over time 
(Figure S7). 
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Figure 4. SRS imaging of NPs in microglia. Microglia were incubated with PLGA-D NPs (A) 
or PLGA-alkyne NPs (B) at 2 × 109 particles mL-1 for 24 hours before fixing and imaging with 
SRS microscopy. Scale bars 20 µm. 
 
As predicted by inspection of the spontaneous Raman spectra in Figure 2, the PLGA-alkyne 
NPs gave a stronger intracellular signal compared to PLGA-D. For this reason, we chose to carry 
out further studies with the PLGA-alkyne NPs only. Using a multi-modal approach to imaging, 
NPs encapsulating rhodamine were visualised using SRS (2128 cm-1, NP) and two photon 
fluorescence (866 nm and 1064 nm, rhodamine) and the signals were shown to co-localise after 
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24 h incubation demonstrating that this model payload could be delivered to microglia using 
these novel PLGA-alkyne NPs (Figure S8). 
We then went on to investigate the uptake of the alkyne NPs in ex vivo mouse brain slices. 
These slices were freshly harvested from mice pups and cultured, bridging the gap between in 
vitro cell culture and in vivo experiments in rodents.36 The slices were incubated with alkyne NPs 
at 2 × 108 and 2 × 109 particles mL-1 for 24 hours before washing, fixing and imaging with SRS 
microscopy. SRS imaging at 2128 cm-1 showed that there are alkyne NPs distributed throughout 
the tissue. 
To determine if the NPs were inside cells in the brain tissue, and what type of cells these were, 
a multimodal imaging technique of both immunofluorescence and Raman imaging was 
employed. Immunofluorescence uses primary antibodies which bind to markers specific to a 
certain cell type, and then secondary fluorescent antibodies so that the cells can be visualised by 
fluorescence microscopy. We used a primary antibody to the protein IBA1, which is found 
specifically on microglia, and also an antibody to OLIG2 to label oligodendroglia, which are glia 
that would not be expected to phagocytose NPs. Figure 5A shows the immunostained tissue with 
microglia in red, oligodendrocytes in green and NPs in magenta. This clearly shows the 
association of the NPs with microglia at both concentrations tested. Z-stack analysis of the tissue 
also allowed depth analysis of the NP location, with Figure 5B showing a Z-stack with 
orthogonal views of the tissue. It is clear from this image that the NPs have been internalised by 
microglia, although there are many other microglia that do not contain NPs, suggesting that 
uptake is not as homogeneous as it was with the in vitro microglia cultures.  
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Figure 5. Imaging alkyne NPs in ex vivo brain slices. A) Alkyne NPs were added to ex vivo 
mouse cortical brain slices at 2 × 108 and 2 × 109 particles mL-1 for 24 hours before washing, 
fixing and immunostaining. Microglia are shown in red (using antibodies against IBA1), 
oligodendrocytes in green (using antibodies against OLIG2) and NPs in magenta. Scale bars 20 
µm. B) Orthogonal views of Z-stack images show that the NPs are inside microglia. Scale bar 20 
µm. 
These experiments have highlighted the clear capability of SRS to image our novel PLGA-
alkyne NPs in ex vivo brain tissue, and show that they are preferentially taken up by microglia 
over oligodendroglia, which give them potential for targeted drug delivery.  
 
CONCLUSIONS 
Raman imaging, and specifically SRS microscopy, have the potential to give non-invasive 
information about the location and state of polymeric nanocarriers in biological environments. 
We have developed two Raman active analogues of PLGA, one of the most commonly used 
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biodegradable polymers for drug delivery research with a long history and proven safety 
record,37 and have used the location of these deuterium and alkyne tags in the cell-silent region 
to enhance contrast of the NPs in a biological environment. As neither deuterium nor alkyne 
bonds are present in biological samples, the signal is certain to derive from the NPs. These NPs 
have been shown to be non-toxic to living cells and SRS imaging has shown that both PLGA-D 
and PLGA-alkyne NPs are internalized in primary rat microglia, and additionally the PLGA-
alkyne NPs were imaged in mouse cortical ex vivo brain slices. We believe that the strong 
Raman signal obtained from the alkyne NPs gives them an especially wide ranging imaging 
potential in many biological applications, including live animal studies which will be a focus of 
our future work.  
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